Latest News
J&J Acquires Halda Therapeutics to Boost Oncology Pipeline
Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion in cash, a transaction announced on 17 November 2025 and expected to close in the coming months, subject to customary regulatory approvals. Halda’s Novel RIPTAC Modality Halda...
Latest News
UK Life Sciences Growth Spreads Beyond London, Oxford and Cambridge
London, Oxford and Cambridge have long been the heartlands of the UK life sciences sector, but other regions across the country are now rapidly emerging as centres of innovation. The Midlands, the North of England, Scotland and Northern Ireland are developing strong...
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Concerns are mounting that the United Kingdom’s official appraisal framework is systematically underestimating the economic and social value of investments in life sciences manufacturing. Industry bodies and independent analysts warn that the methods used to evaluate...
Trump’s Proposed Drug Tariff Could Reshape the UK Pharma Landscape
It is unusual for trade policy in the United States to have such a direct impact on the UK life sciences sector, but President Donald Trump’s proposed 100 per cent tariff on branded and patented pharmaceuticals could do just that. If enacted, the measure would impose...
Claude for Life Sciences – Major AI Pivot into Drug Discovery and Research
Artificial intelligence company Anthropic is making a significant move into the life sciences sector with the launch of Claude for Life Sciences, a version of its Claude language model platform tailored for scientific research, drug discovery and regulatory workflows....
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
UK Life Sciences Growth Spreads Beyond London, Oxford and Cambridge
London, Oxford and Cambridge have long been the heartlands of the UK life sciences sector, but other regions across the country are now rapidly emerging as centres of innovation. The Midlands, the North of England, Scotland and Northern Ireland are developing strong...
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Concerns are mounting that the United Kingdom’s official appraisal framework is systematically underestimating the economic and social value of investments in life sciences manufacturing. Industry bodies and independent analysts warn that the methods used to evaluate...
Trump’s Proposed Drug Tariff Could Reshape the UK Pharma Landscape
It is unusual for trade policy in the United States to have such a direct impact on the UK life sciences sector, but President Donald Trump’s proposed 100 per cent tariff on branded and patented pharmaceuticals could do just that. If enacted, the measure would impose...
Claude for Life Sciences – Major AI Pivot into Drug Discovery and Research
Artificial intelligence company Anthropic is making a significant move into the life sciences sector with the launch of Claude for Life Sciences, a version of its Claude language model platform tailored for scientific research, drug discovery and regulatory workflows....
Genentech Cuts 87 Jobs in Latest Round of Layoffs at South San Francisco HQ
Genentech has carried out another round of workforce reductions, cutting 87 positions at its South San Francisco headquarters. The layoffs, filed last week and set to take effect on September 15, were disclosed in a California Worker Adjustment and Retraining...
Navigating Life with Haemophilia with Pfizer
Life with haemophilia can be challenging but advances in science are helping people with haemophilia to lead active and fulfilling lives. What is Haemophilia? Haemophilia is a family of rare genetic blood disorders caused by a clotting factor deficiency, which...
UK Crown Estate Buys Harwell East, Opening 4.5m sq ft for Science & Innovation
The Crown Estate has completed the acquisition of Harwell East, a 221 acre site adjacent to the Harwell Science and Innovation Campus in Oxfordshire. The development could deliver up to 4.5 million square feet of laboratory, research, manufacturing and office space,...
Amazon to Launch Prescription Kiosks in LA One Medical Clinics
Amazon is gearing up to roll out prescription kiosks inside One Medical clinics in Los Angeles beginning December 2025. These in office machines will allow patients to collect common prescription medications such as antibiotics, inhalers, and treatments for high blood...
Astatine-211: The Alpha-Emitter Gaining Momentum in Targeted Radiotherapy
Astatine, the heaviest halogen and the rarest naturally occurring element, has long been a scientific curiosity. Among its many isotopes, ²¹¹At has emerged over the past decade as a frontrunner in the quest to harness alpha particles for highly targeted radiotherapy....
Blood Test for 50+ Cancers Shows Promise in Faster Diagnosis
A new multi cancer blood test developed by the United States biotechnology company Grail has demonstrated in North America the ability to detect a wide range of cancers, including many for which no screening programmes exist, at an early and potentially treatable...
Eli Lilly Expands U.S. Manufacturing with Multi-Billion Investment
Eli Lilly & Company is doubling down on U.S. investment, unveiling a series of ambitious plans to expand its domestic pharmaceutical manufacturing infrastructure. These efforts come amid mounting political pressure to reshore drug production and rising competition...
Trump’s Recent Guidance on Tylenol, Vaccines, and Children Draws Fire from Medical Community
In late September 2025, former U.S. President Donald J. Trump revived a series of controversial health claims and policy proposals concerning women especially pregnant women and children, triggering sharp pushback from medical experts, public health authorities, and...
Featured Articles
Further News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.





